Invention Grant
- Patent Title: Tetrahydronaphthyridine somatostatin receptor 5 antagonists
- Patent Title (中): 四氢萘并嘧啶生长抑素受体5拮抗剂
-
Application No.: US14505907Application Date: 2014-10-03
-
Publication No.: US09353108B2Publication Date: 2016-05-31
- Inventor: Shizuo Kasai , Hideki Hirose , Takeshi Yamasaki , Tohru Yamashita , Asato Kina
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Foley & Lardner LLP
- Priority: JP2013-209826 20131007
- Main IPC: C07D471/04
- IPC: C07D471/04

Abstract:
A compound having an SSTR5 antagonist action and use of the compound as a medicament are provided. Specifically, a compound represented by the following formula: wherein each symbol is as defined herein, or a salt thereof, a medicament comprising the compound or a salt thereof, and use of the compound or a salt thereof as an agent for the prophylaxis or treatment of diabetes mellitus are provided.
Public/Granted literature
- US20150099777A1 HETEROCYCLIC COMPOUND Public/Granted day:2015-04-09
Information query